CYP Still has plenty of legs from it's current SP/Mcap I agree. Eager to see where they are at in another year or two.
Health industry as a whole will be in for a good year IMO. Particularly Stem cells and Tech health.
MEB, CYP, IMU, PTX, etc.
- Forums
- Commodities
- Biotech 2017
Biotech 2017, page-2
-
- There are more pages in this discussion • 74 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Featured News
The Watchlist
CC9
CHARIOT CORPORATION LTD
MD - Shanthar Pathmanathan, Geologist - David Trabert
MD - Shanthar Pathmanathan
Geologist - David Trabert
SPONSORED BY The Market Online